A nomogram was constructed using variables such as nodule type, pleural traction, vascular convergence, CEA levels, and maximum diameter to predict STAS in patients with stage IA lung adenocarcinoma (Figure 2). This evidence concerns the gene CEACAM5 and lung adenocarcinoma.